AAAAAA
Results:
1-10
|
Results: 10
Authors:
Yueh, B
Souza, PE
McDowell, JA
Collins, MP
Loovis, CF
Hedrick, SC
Ramsey, SD
Deyo, RA
Citation: B. Yueh et al., Randomized trial of amplification strategies, ARCH OTOLAR, 127(10), 2001, pp. 1197-1204
Authors:
McDowell, JA
Lou, Y
Symonds, WS
Stein, DS
Citation: Ja. Mcdowell et al., Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults, ANTIM AG CH, 44(8), 2000, pp. 2061-2067
Authors:
McDowell, JA
Chittick, GE
Stevens, CP
Edwards, KD
Stein, DS
Citation: Ja. Mcdowell et al., Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults, ANTIM AG CH, 44(6), 2000, pp. 1686-1690
Authors:
Chen, XY
McDowell, JA
Kierzek, R
Krugh, TR
Turner, DH
Citation: Xy. Chen et al., Nuclear magnetic resonance spectroscopy and molecular modeling reveal thatdifferent hydrogen bonding patterns are possible for G center dot U pairs:One hydrogen bond for each G center dot U pair in r(GGC(GU)under-bar-GCC)(2) and two for each G center dot U pair in r(GAG(UG)under-bar-CUC)(2), BIOCHEM, 39(30), 2000, pp. 8970-8982
Authors:
Chittick, GE
Gillotin, C
McDowell, JA
Lou, Y
Edwards, KD
Prince, WT
Stein, DS
Citation: Ge. Chittick et al., Abacavir: Absolute bioavailability, bioequivalence of three oral formulations, and effect of food, PHARMACOTHE, 19(8), 1999, pp. 932-942
Authors:
Wang, LH
Chittick, GE
McDowell, JA
Citation: Lh. Wang et al., Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine,and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection, ANTIM AG CH, 43(7), 1999, pp. 1708-1715
Authors:
Kumar, PN
Sweet, DE
McDowell, JA
Symonds, W
Lou, Y
Hetherington, S
LaFon, S
Citation: Pn. Kumar et al., Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults, ANTIM AG CH, 43(3), 1999, pp. 603-608
Authors:
Hughes, W
McDowell, JA
Shenep, J
Flynn, P
Kline, MW
Yogev, R
Symonds, W
Lou, Y
Hetherington, S
Citation: W. Hughes et al., Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children, ANTIM AG CH, 43(3), 1999, pp. 609-615
Authors:
McDowell, JA
Chittick, GE
Ravitch, JR
Polk, RE
Kerkering, TM
Stein, DS
Citation: Ja. Mcdowell et al., Pharmacokinetics of [C-14]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral doseto HIV-1-infected adults: a mass balance study, ANTIM AG CH, 43(12), 1999, pp. 2855-2861
Authors:
Kline, MW
Blanchard, S
Fletcher, CV
Shenep, JL
McKinney, RE
Brundage, RC
Culnane, M
Van Dyke, RB
Dankner, WM
Kovacs, A
McDowell, JA
Hetherington, S
Citation: Mw. Kline et al., A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection, PEDIATRICS, 103(4), 1999, pp. E471-E475
Risultati:
1-10
|